Graybug Vision Inc (GRAY) Stock
GRAY is no longer traded. Graybug Vision was delisted from the Nasdaq in May 2023.
Prices on this page are historical; the last trade was May 22, 2023 at $2.95.
Graybug Vision stock price history
GRAY final trading statistics
- Final close
- $2.95
- Final trading day
- May 22, 2023
- Market cap at delisting
- $64.89M
- Shares outstanding
- 22.00M
- Final 52-week range
- $0.44 – $7.10
- Avg. volume (final 3 mo.)
- 18,643
- All-time high (split-adj.)
- $490.00 · Jan 2021
- All-time low (split-adj.)
- $2.15 · Apr 2023
- Return since IPO
- -98.7%
- Beta
- 1.20
- Book value / share
- $1.66
- Price / book
- 1.78
Graybug Vision annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $2.96M | -$35.0M | -$1.66 |
| FY2021 | $0.00 | -$35.3M | -$1.69 |
| FY2020 | $0.00 | -$24.8M | -$4.68 |
| FY2019 | $0.00 | -$36.6M | — |
| FY2018 | $0.00 | -$28.4M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Graybug Vision Inc
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.
Graybug Vision stock FAQ
What happened to Graybug Vision stock?
Graybug Vision stock was delisted from the Nasdaq. Its final close was $2.95 on May 22, 2023.
Is GRAY stock still trading?
No. GRAY was delisted from the Nasdaq in May 2023 and no longer trades on a U.S. exchange.
What was the last price of GRAY stock?
GRAY closed at $2.95 on its final trading day, May 22, 2023, for a market value of about $64.89M.
What were Graybug Vision's revenue and earnings in its last full fiscal year?
Graybug Vision reported revenue of $2.96M and net income of -$35.0M in fiscal 2022, its last full year as a public company.
When did Graybug Vision go public?
Graybug Vision Inc stock began trading on September 25, 2020.